| RÉDOVÁ, Martina, Alexandr POPRACH, Jana NEKVINDOVÁ, Robert ILIEV, Lenka RADOVÁ, Radek LAKOMÝ, Marek SVOBODA, Rostislav VYZULA and Ondřej SLABÝ. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. Journal of Translational Medicine. London: Biomed Central, 2012, vol. 10, March, p. "nestránkováno", 8 pp. ISSN 1479-5876. Available from: https://dx.doi.org/10.1186/1479-5876-10-55. |
Other formats:
BibTeX
LaTeX
RIS
@article{984202,
author = {Rédová, Martina and Poprach, Alexandr and Nekvindová, Jana and Iliev, Robert and Radová, Lenka and Lakomý, Radek and Svoboda, Marek and Vyzula, Rostislav and Slabý, Ondřej},
article_location = {London},
article_number = {March},
doi = {http://dx.doi.org/10.1186/1479-5876-10-55},
keywords = {Renal cell carcinoma; MicroRNA; Serum; Biomarker},
language = {eng},
issn = {1479-5876},
journal = {Journal of Translational Medicine},
title = {Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma},
url = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340316/?tool=pubmed},
volume = {10},
year = {2012}
}
TY - JOUR
ID - 984202
AU - Rédová, Martina - Poprach, Alexandr - Nekvindová, Jana - Iliev, Robert - Radová, Lenka - Lakomý, Radek - Svoboda, Marek - Vyzula, Rostislav - Slabý, Ondřej
PY - 2012
TI - Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
JF - Journal of Translational Medicine
VL - 10
IS - March
SP - "nestránkováno"
EP - "nestránkováno"
PB - Biomed Central
SN - 14795876
KW - Renal cell carcinoma
KW - MicroRNA
KW - Serum
KW - Biomarker
UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340316/?tool=pubmed
L2 - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340316/?tool=pubmed
N2 - There is no standard serum biomarker used for diagnosis or early detection of recurrence for renal cell carcinoma (RCC) patients. MicroRNAs (miRNAs) are abundant and highly stable in blood serum, and have been recently described as powerful circulating biomarkers in a wide range of solid cancers. Our aim was to identify miRNA signature that can distinguish the blood serum of RCC patients and matched healthy controls and validate identified miRNAs as potential biomarkers for RCC.
ER -
RÉDOVÁ, Martina, Alexandr POPRACH, Jana NEKVINDOVÁ, Robert ILIEV, Lenka RADOVÁ, Radek LAKOMÝ, Marek SVOBODA, Rostislav VYZULA and Ondřej SLABÝ. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. \textit{Journal of Translational Medicine}. London: Biomed Central, 2012, vol.~10, March, p.~''nestránkováno'', 8 pp. ISSN~1479-5876. Available from: https://dx.doi.org/10.1186/1479-5876-10-55.
|
